Fact CheckerSign in

NCT05384626RecruitingPhase 1/2

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

A Phase 1/2 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors (ALKOVE-1)

Source: ClinicalTrials.gov · Last updated 27 May 2026

Brief summary (registry, in English)

Phase 1/2, dose escalation and expansion study designed to evaluate the safety and tolerability of neladalkib (NVL-655), determine the recommended phase 2 dose (RP2D), and evaluate the antitumor activity in patients with advanced ALK- positive (ALK+) NSCLC and other solid tumors. Phase 1 will evaluate the overall safety and tolerability of neladalkib and will determine the RP2D and, if applicable, the maximum tolerated dose (MTD) of neladalkib in patients with advanced ALK+ solid tumors. Phase 2 will determine the objective response rate (ORR) as assessed by Blinded Independent Central Review (BICR) of neladalkib at the RP2D. Secondary objectives will include the duration of response (DOR), time to response (TTR), progression-free survival (PFS), overall survival (OS), and clinical benefit rate (CBR) of neladalkib in patients with advanced ALK-positive NSCLC and other solid tumors. A drug-drug interaction (DDI) sub-study will determine the effect of neladalkib on the pharmacokinetics of midazolam and repaglinide, as well as the effect of itraconazole on the pharmacokinetics of neladalkib, in patients with advanced ALK-positive NSCLC

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
840 (estimated)
First submitted
17 May 2022
Start date
9 Jun 2022
Primary completion date
Dec 2027
Lead sponsor
Nuvalent Inc.
NCT number
NCT05384626
EU CT number
2024-514266-39-00
EudraCT number
2022-000122-21

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 840
  • From 9 Jun 2022 to the primary completion date, Dec 2027
  • 75 sites in 15 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Major surgery within 4 weeks of the study entry
  • Ongoing or anticancer therapy
  • Actively receiving systemic treatment or direct medical intervention on another therapeutic clinical study.

Other illness

  • Patient's cancer has a known oncogenic driver alteration other than ALK.
  • Known allergy/hypersensitivity to excipients of NVL-655.

Who the study is looking for

  • Age ≥18 years, Phase 2 Cohort 2f only: Age ≥12 years and weighing \>40 kg. DDI sub-study Cohorts G and H only: age 18-60 years, inclusive
  • Phase 1: Histologically or cytologically confirmed locally advanced or metastatic solid tumor with a documented ALK rearrangement or activating ALK mutation.
  • Phase 2
    • Phase 2 Cohorts except 2f: Histologically or cytologically confirmed locally advanced or metastatic NSCLC with a documented ALK rearrangement
    • Phase 2 Cohort 2f: Histologically or cytologically confirmed locally advanced or metastatic solid tumor with a documented ALK rearrangement or activating ALK mutation detected by certified assay.
  • DDI sub-study cohorts: Histologically or cytologically confirmed locally advanced or metastatic NSCLC with a documented ALK rearrangement
  • DDI sub-study cohorts: Must have previously received ≥1 ALK TKI; no prior investigational agents targeting ALK; any number of prior chemotherapy and/or immunotherapy
  • Phase 1: Must have evaluable disease (target or nontarget) according to RECIST 1.1 Phase 2: Must have measurable disease according to RECIST 1.1
  • Adequate organ function and bone marrow reserve

Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (75)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Peter MacCallum Cancer Centre
Coordinator of this site? Confirm its status
MelbourneAustraliaRecruiting
Royal North Shore Hospital
Coordinator of this site? Confirm its status
SydneyAustraliaRecruiting
Princess Alexandra Hospital
Coordinator of this site? Confirm its status
WoolloongabbaAustraliaRecruiting
Antwerp University Hospital
Coordinator of this site? Confirm its status
EdegemBelgiumRecruiting
UZ Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumRecruiting
Cross Cancer Institute
Coordinator of this site? Confirm its status
EdmontonCanadaRecruiting
The Ottawa Hospital Cancer Center
Coordinator of this site? Confirm its status
OttawaCanadaRecruiting
Princess Margaret Cancer Centre
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting
BC Cancer Center
Coordinator of this site? Confirm its status
VancouverCanadaRecruiting
Istituto Oncologico Svizzera Italiana
Coordinator of this site? Confirm its status
BellinzonaSwitzerlandRecruiting
Luzerner Kantonsspital
Coordinator of this site? Confirm its status
LucerneSwitzerlandRecruiting
University Hospital Cologne AöR
Coordinator of this site? Confirm its status
CologneGermanyRecruiting
Goethe University Frankfurt
Coordinator of this site? Confirm its status
Frankfurt Am MainGermanyRecruiting
LungenClinic Grosshansdorf GmbH
Coordinator of this site? Confirm its status
GrosshansdorfGermanyRecruiting
Thoraxklinik Heidelberg gGmbH
Coordinator of this site? Confirm its status
HeidelbergGermanyRecruiting
Complexo Hospitalario Universitario A Coruña
Coordinator of this site? Confirm its status
A CoruñaSpainRecruiting
Micancer Center S.L.P.
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Hospital Universitario 12 de Octubre
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital General Universitario Gregorio Marañón
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital Universitario HM Sanchinarro
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Centre Leon Berard
Coordinator of this site? Confirm its status
LyonFranceRecruiting
Centre Hospitalier Universitaire de Nantes
Coordinator of this site? Confirm its status
Saint-HerblainFranceRecruiting
Oncopole Claudius Regaud
Coordinator of this site? Confirm its status
Toulouse Cedex 9FranceRecruiting
Institut Gustave Roussy
Coordinator of this site? Confirm its status
VillejuifFranceRecruiting
Edinburgh Cancer Centre
Coordinator of this site? Confirm its status
EdinburghUnited KingdomRecruiting
The Royal Marsden - Chelsea
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
The Christie NHS Foundation Trust
Coordinator of this site? Confirm its status
ManchesterUnited KingdomRecruiting
Royal Marsden Hospital
Coordinator of this site? Confirm its status
SuttonUnited KingdomRecruiting
Azienda Ospedaliero-Universitaria delle Marche
Coordinator of this site? Confirm its status
AnconaItalyRecruiting
Istituto Tumori Bari Giovanni Paolo II
Coordinator of this site? Confirm its status
BariItalyRecruiting
Fondazione IRCCS - Istituto Nazionale dei Tumori
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Istituto Europeo di Oncologia s.r.l
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Istituto Oncologico Veneto
Coordinator of this site? Confirm its status
PadovaItalyRecruiting
Azienda Unità Sanitaria Locale della Romagna
Coordinator of this site? Confirm its status
RavennaItalyRecruiting
I.F.O. Istituti Fisioterapici Ospitalieri
Coordinator of this site? Confirm its status
RomeItalyRecruiting
Kanagawa Cancer Center
Coordinator of this site? Confirm its status
KanagawaJapanRecruiting
Okayama University Hospital
Coordinator of this site? Confirm its status
OkayamaJapanRecruiting
Kindai University Hospital
Coordinator of this site? Confirm its status
OsakaJapanRecruiting
Shizuoka Cancer Center
Coordinator of this site? Confirm its status
ShizuokaJapanRecruiting
Cancer Institute Hospital of JFCR
Coordinator of this site? Confirm its status
TokyoJapanRecruiting
National Cancer Center Hospital
Coordinator of this site? Confirm its status
TokyoJapanRecruiting
Wakayama Medical University Hospital
Coordinator of this site? Confirm its status
WakayamaJapanRecruiting
National Cancer Center
Coordinator of this site? Confirm its status
Goyang-siSouth KoreaRecruiting
Seoul National University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaRecruiting
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaRecruiting
Severance Hospital, Yonsei University Health System
Coordinator of this site? Confirm its status
SeoulSouth KoreaRecruiting
Netherlands Cancer Institute
Coordinator of this site? Confirm its status
AmsterdamNetherlandsRecruiting
Universitair Medisch Centrum Groningen
Coordinator of this site? Confirm its status
GroningenNetherlandsRecruiting
National University Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeRecruiting
National Cancer Centre Singapore
Coordinator of this site? Confirm its status
SingaporeSingaporeRecruiting
Chung Shan Medical University Hospital
Coordinator of this site? Confirm its status
TaichungTaiwanRecruiting
National Cheng Kung University Hospital
Coordinator of this site? Confirm its status
TainanTaiwanRecruiting
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting
Winship Cancer Institute, Emory University
Coordinator of this site? Confirm its status
AtlantaUnited StatesRecruiting
University of Colorado Cancer Center
Coordinator of this site? Confirm its status
AuroraUnited StatesRecruiting
John Hopkins University
Coordinator of this site? Confirm its status
BaltimoreUnited StatesRecruiting
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
University of Chicago Medical Center
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting
OSU Brain & Spine Hospital
Coordinator of this site? Confirm its status
ColumbusUnited StatesRecruiting
Henry Ford Cancer Institute
Coordinator of this site? Confirm its status
DetroitUnited StatesRecruiting
Duke University Medical Center
Coordinator of this site? Confirm its status
DurhamUnited StatesRecruiting
MD Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesActive, not recruiting
University of Miami - Sylvester Cancer Center
Coordinator of this site? Confirm its status
MiamiUnited StatesRecruiting
Sarah Cannon
Coordinator of this site? Confirm its status
NashvilleUnited StatesRecruiting
Memorial Sloan-Kettering Cancer Center
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
University of California Irvine Medical Center
Coordinator of this site? Confirm its status
OrangeUnited StatesRecruiting
University of Pennsylvania/Abramson Cancer Center
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
University of California Davis Comprehensive Cancer Center
Coordinator of this site? Confirm its status
SacramentoUnited StatesRecruiting
Fred Hutchinson Cancer Center
Coordinator of this site? Confirm its status
SeattleUnited StatesRecruiting
Stanford Cancer Institute
Coordinator of this site? Confirm its status
StanfordUnited StatesRecruiting
Washington University School of Medicine - Siteman Cancer Center
Coordinator of this site? Confirm its status
St LouisUnited StatesRecruiting
Georgetown University Medical Center
Coordinator of this site? Confirm its status
Washington D.C.United StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.